Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/82277
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorDepartment of Health Technology and Informatics-
dc.creatorWu, J-
dc.creatorSu, HK-
dc.creatorYu, ZH-
dc.creatorXi, SY-
dc.creatorGuo, CC-
dc.creatorHu, ZY-
dc.creatorQu, Y-
dc.creatorCai, HP-
dc.creatorZhao, YY-
dc.creatorZhao, HF-
dc.creatorChen, FR-
dc.creatorHuang, YF-
dc.creatorTo, SST-
dc.creatorFeng, BH-
dc.creatorSai, K-
dc.creatorChen, ZP-
dc.creatorWang, J-
dc.date.accessioned2020-05-05T05:59:23Z-
dc.date.available2020-05-05T05:59:23Z-
dc.identifier.urihttp://hdl.handle.net/10397/82277-
dc.language.isoenen_US
dc.publisherBioMed Centralen_US
dc.rights© The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.en_US
dc.rightsThe following publication Wu, J., Su, H., Yu, Z. et al. Skp2 modulates proliferation, senescence and tumorigenesis of glioma. Cancer Cell Int 20, 71 (2020) is available at https://dx.doi.org/10.1186/s12935-020-1144-zen_US
dc.subjectGliomaen_US
dc.subjectS-phase kinase-associated protein 2 (Skp2)en_US
dc.subjectGlioma stem-like cellsen_US
dc.subjectLovastatinen_US
dc.subjectSZL-P1-41en_US
dc.titleSkp2 modulates proliferation, senescence and tumorigenesis of gliomaen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.spage1-
dc.identifier.epage11-
dc.identifier.volume20-
dc.identifier.doi10.1186/s12935-020-1144-z-
dcterms.abstractBackground: Gliomas represent the largest class of primary central nervous system neoplasms, many subtypes of which exhibit poor prognoses. Surgery followed by radiotherapy and chemotherapy has been used as a standard strategy but yielded unsatisfactory improvements in patient survival outcomes. The S-phase kinase protein 2 (Skp2), a critical component of the E3-ligase SCF complex, has been documented in tumorigenesis in various cancer types but its role in glioma has yet to be fully clarified. In this study, we investigated the function of Skp2 in the proliferation, stem cell maintenance, and drug sensitivity to temozolomide (TMZ) of glioma.-
dcterms.abstractMethods: To investigate the role of Skp2 in the prognosis of patients with glioma, we first analyzed data in databases TCGA and GTEx. To further clarify the effect of Skp2 on glioma cell proliferation, we suppressed its level in glioblastoma (GBM) cell lines through knockdown and small molecule inhibitors (lovastatin and SZL-P1-41). We then detected cell growth, colony formation, sphere formation, drug sensitivity, and in vivo tumor formation in xenograft mice model.-
dcterms.abstractResults: Skp2 mRNA level was higher in both low-grade glioma and GBM than normal brain tissues. The knockdown of Skp2 increased cell sensitivity to TMZ, decreased cell proliferation and tumorigenesis. In addition, Skp2 level was found increased upon stem cells enriching, while the knockdown of Skp2 led to reduced sphere numbers. Downregulation of Skp2 also induced senescence. Repurposing of lovastatin and novel compound SZL-P1-41 suppressed Skp2 effectively, and enhanced glioma cell sensitivity to TMZ in vitro and in vivo.-
dcterms.abstractConclusion: Our data demonstrated that Skp2 modulated glioma cell proliferation in vitro and in vivo, stem cell maintenance, and cell sensitivity to TMZ, which indicated that Skp2 could be a potential target for long-term treatment.-
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationCancer cell international, 6 Mar. 2020, v. 20, 71, p. 1-11-
dcterms.isPartOfCancer cell international-
dcterms.issued2020-
dc.identifier.isiWOS:000519067200003-
dc.identifier.scopus2-s2.0-85081271393-
dc.identifier.pmid32165861-
dc.identifier.eissn1475-2867-
dc.identifier.artn71-
dc.description.validate202006 bcrc-
dc.description.oaVersion of Recorden_US
dc.identifier.FolderNumberOA_Scopus/WOSen_US
dc.description.pubStatusPublisheden_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
Wu_Skp2_Senescence_Tumorigenesis.pdf7.29 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

79
Last Week
3
Last month
Citations as of Mar 24, 2024

Downloads

62
Citations as of Mar 24, 2024

SCOPUSTM   
Citations

30
Citations as of Mar 28, 2024

WEB OF SCIENCETM
Citations

26
Citations as of Mar 28, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.